Literature DB >> 940115

Tissue distribution of technetium-99m and carbon-14 labeled N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid.

P S Callery, W C Faith, M D Loberg, A T Fields, E B Harvey, M D Cooper.   

Abstract

The synthesis, radiochemical labeling, and tissue distribution characteristics of N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid are described. The radiopharmaceutical prepared by labeling with 99mTc was rapidly eliminated through the hepato-biliary system of mice. Parent 14C compound was eliminated primarily through the kidney. The 99mTc ion appears to have a greater influence than the organic carrier molecule on the distribution of the radiopharmaceutical.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 940115     DOI: 10.1021/jm00229a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Imaging inflammation with human polyclonal immunoglobulin: not looked for but discovered.

Authors:  F H Corstens; R A Claessens
Journal:  Eur J Nucl Med       Date:  1992

2.  Comparison of two different biliary agents in healthy subjects and in patients with liver disease.

Authors:  R Dudczak; K Kletter; P Angelberger; H Frischauf
Journal:  Eur J Nucl Med       Date:  1979-10

3.  Estimation of 99mTc-diethyl-IDA liver clearance.

Authors:  M Erjavec; S Pahor; D B Poreko; J Snajder
Journal:  Eur J Nucl Med       Date:  1982

4.  The stability and distribution of Tc-HIDA in vivo and in vitro.

Authors:  M A Zivanovic; D M Taylor; V R McCready; S T Meller
Journal:  Eur J Nucl Med       Date:  1979-10

Review 5.  Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems.

Authors:  W C Eckelman
Journal:  Eur J Nucl Med       Date:  1995-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.